Live feed
Filing
SC 13G
SC 13G0000899140-22-000569·Fulcrum Therapeutics, Inc.
Schedule 13G ownership disclosure
Fulcrum Therapeutics Inc
Security class unavailable · CUSIP: 359616109
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,750,000
- Percent of class
- 4.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-22-000569
- Form type
- SC 13G
- Filer
- Fulcrum Therapeutics, Inc.
- CIK
- CIK 1680581
- Filed
- Jun 22, 2022
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership